REGENXBIO Inc. (RGNX) stock chart

RGNXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30

$7.64−0.39 (-4.86%)

Close on Nov 13, 2026Market cap $504.34MP/E –Yield –

Daily, weekly, monthly, quarterly and yearly candles from end-of-day prices, adjusted for splits. Marks along the bottom: E for earnings, D for ex-dividend dates, S for stock splits. Drawings are saved in this browser for each symbol; indicators and chart settings carry across symbols.

See a number that looks wrong?